INTRODUCTION
Patients with ragweed hay fever show positive, direct, wheal-and-flare skin reactions to extracts of ragweed pollen and have IgE antibodies specific for ragweed antigens in their serum (1, 2) . These IgE antibodies may be measured in vitro by coprecipitation with radiolabeled antigen (3), by passive leukocyte sensitization (4) or by the radioallergosorbent test (RAST)1 (5) . With passive leukocyte sensitization, IgE antibodies can be readily measured in the serums of children with ragweed hay fever, whereas IgE antibodies are detectable in only about 50% of adult patients with this method (6, 7) .
After the ragweed pollination season, IgE antibodies in serum increase in concentration, and in children this increase appears to be partially suppressed by immunotherapy (6) . Cells of the treated subjects become less sensitive or less reactive to ragweed antigen E (AgE) (6, 7) , and IgG antibodies ("blocking" antibodies) appear in the serum (8) (9) (10) . The apparent suppression of IgE antibody has been attributed to the presence of IgGblocking antibody (6) .
We have analyzed serums from normal individuals and patients with ragweed hay fever to define the immunological mechanisms operating during immunotherapy. The results indicate that rises in IgE antibodies during the ragweed pollination season are not suppressed by immunotherapy. In treated patients, IgE and IgG antibodies were positively correlated, a finding contrary to that expected if IgG antibody were acting to suppress production of IgE antibody.
METHODS
Patient groups. 62 patients were studied during 1970 and were divided into four groups. 10 healthy nonallergic persons served as controls. 52 patients with typical ragweed 1 Abbreviations used in this paper: AgE, ragweed antigen E (partially purified); AgE IV-C, ragweed antigen E (highly purified); PNU, protein nitrogen units; RAST, radioallergosorbent test. hay fever were subdivided into three groups: one received no immunotherapy; a second began immunotherapy in the spring of 1970; a third group was already receiving high dose perennial immunotherapy with aqueous-mixed ragweed pollen extract. The patients in the high dose-treated group had received immunotherapy for at least 2 yr (one patient for as long as 19 yr); the median length of treatment was 4 yr. In 1968 and 1969 the high dose group had received an average total dose of 113,000 and 272,000 protein nitrogen units (PNU), respectively. In 1970 the range of doses for patients in this group was 170,000-381,000 PNU, and the median dose was 259,000 PNU. All of these patients continued to receive monthly injections of pollen extract during the study period.
Only one of the nonallergic normals had a positive direct wheal-and-flare skin reaction to ragweed extract (and this to a high concentration), whereas all of the allergic subjects reacted positively. The characteristics of these groups and the cumulative dose of ragweed pollen extract received during 1970 are listed in Table I . None of the patients received corticosteroids. 10 of the 52 allergic patients had occasional wheezing episodes during the ragweed pollination season, but asthma was a major problem in only five patients. None of the patients had atopic dermatitis.
Four serum samples were collected: one at the beginning of the study, before the onset of the ragweed pollination season, in April (the group beginning immunotherapy) or July 1970; the second at the height of the ragweed pollination season in late August or very early September; the third in mid-October; and the fourth in January 1971. Serum samples were obtained within a few minutes of the pollen extract injection in the treated groups. The serums obtained in April from the group beginning immunotherapy were drawn before the first injection of pollen extract.
IgE antibody to ragweed AgE. Serum IgE antibody to ragweed AgE was measured by means of the RAST procedure (5, 11) . In this method AgE is bound to a solid phase carrier and incubated with serum. After a washing procedure the solid phase antigen is reacted with radiolabeled antibody to IgE, again washed, and counted. The radioactivity associated with the solid phase antigen is taken as a measure of the IgE antibody level. Partially purified AgE was reacted with cyanogen bromide-activated microcrystalline cellulose to yield a solid phase ragweed antigen.
The detailed description of these procedures as well as the purification of AgE is presented elsewhere (12) . Briefly, ragweed pollen was defatted, extracted with distilled water, and purified by gel filtration through Sephadex G-25. The void volume peak containing AgE activity was concentrated and further purified by gel filtration on Sephadex G-100. The resulting partially purified AgE contained 4.6 mg protein/ml, of which 50% was AgE as measured by radioimmunoassay (13) . In all of the analyses of IgE and IgG antibodies to AgE the same lot of partially purified AgE was utilized. In the remainder of this paper the term AgE will refer to this partially purified preparation, and AgE IV-C 2 will be used to designate the more highly purified protein of King, Norman, and Connell (14) . After thorough washing to remove noncovalently bound AgE, the cellulose-AgE polymer was suspended at a concentration of 1 mg/ml in 0. again with pH 4.0 0.1 M sodium acetic acid, and a third time with borate-saline. Sheep anti-IgE (4 ml) was applied to a column (1.2 X 6.5 cm) of Sepharose-IgE, and, after washing with borate-saline, the anti-IgE was eluted with pH 2.9 0.05 M glycine-HCl. The 277 nm absorbance recovered after acid elution constituted 9.5% of the total applied. The purified anti-IgE (867 gg/ml) migrated in the fast gamma region and gave a single band when reacted with a potent rabbit anti-whole sheep serum in immunoelectrophoresis.
Purified anti-IgE (17 gg) was radiolabeled with 2 mCi 51 or "'1I by a modification of the technique of Greenwood, Hunter, and Glover (17) as described previously (16) . The radiolabeled purified antibody was separated from unreacted radioiodine by gel filtration on Sephadex G-100 columns.
Between 96-99% of the radioactivity in the labeled antiserum was precipitated by 10% phosphotungstic acid. A portion of radiolabeled anti-IgE was reapplied to a small Sepharose-IgE column; 65% of counts bound and were eluted with pH 2.9 0.05 M glycine-HCl.
The RAST procedure was carried out by mixing 0.5 mg solid phase AgE in 0.5 ml buffer, 0.05 ml test serum, and 0.2 ml diluent in 10 X 44-mm tubes (Fisher Scientific Co., Pittsburgh, Pa.). The tubes were capped and were slowly rotated overnight at room temperature, after which they were centrifuged at 3,420 g for 15 min and the supernate aspirated. The solid phase AgE was washed thrice with 1 ml of 0.1 M phosphate buffer (pH 7.4) containing l1o% Tween 20 . Approximately 1.4 ng of the radio-labeled sheep anti-IgE was added to each tube and the volume adjusted to 0.75 ml. The tubes were rotated overnight and washed again. Radioactive counts associated with the final washed polymer were measured in a gamma spectrometer, and the results were expressed as counts bound divided by counts added, X 100. In all of these studies the same batch of cellulose-AgE l)olymer was used. In preliminary experimenits the specificity of the RAST for IgE antibody was Changes in IgE Antibodies during Immunotherapy for Ragweed Hay Fever Measutremnent of IgG antibodies. IgG-blocking antibodies were measured in preseasonal and peak seasonal serums by radioimmunoprecipitation (3, 18, 19) . Partially purified AgE (4.6 mg) was radiolabeled with 2 mCi "31I by the chloramine-T method (17) , and free "31I was removed by dialysis against pH 7.3 0.01 M K2HPO4-KH2PO4 0.13 M NaCl phosphate-buffered saline (PBS) until the radioactive counts in the dialysate were negligible. About 98% of the total radioactivity in the retentate was precipitable by 10% phosphotungstic acid. Radiolabeled AgE was added to 0.01 ml patient serum and diluted with 0.2 ml of 1% BSA in pH 7.4 0.1 M phosphate buffer in 10 X 75-mm glass tubes. The tubes were incubated for 1 h at 37°C, then overnight at 4°C, and 0.25 ml of goat antihuman IgG was added. After a second incubation for 1 h at 370C, and overnight at 4°C, the resulting precipitates were centrifuged at 3,420 g for 30 min at 40C and washed thrice with 3 ml aliquots of pH 7.4 0.1 M phosphate buffer. The radioactivity associated with the washed precipitates from test serum was measured in a gamma spectrometer. As shown in Fig. la , addition of increasing amounts of radiolabeled antigen resulted in the formation of plateau or maximum binding regions, and as shown in Fig. lb , the quantity of AgE bound was linearly related to the quantity of serum analyzed. In the assay of serum from the study groups 1000 ng of radio-labeled AgE was added to 0.01 ml of patient serum, and results were recorded as nanograms of AgE bound per 0.01 ml of patient serum. As controls in these determinations a serum from a treated patient with a high level of binding (100 ng/0.01 ml) and another from a normal subject with low binding (1 ng/0.01 ml) were analyzed. The coefficients of variation for these serums were 8.1 and 20.8, respectively.
Statistical evaluation of data. Numerical results were compared using nonparametric statistical methods (20) , such as the sign test, the signed rank test, the rank sum test, and the rank correlation test. For samples with n greater than 10 we applied the normal approximation of the rank sum test. For comparison of rises in IgE antibody, data were tested by analysis of covariance.
RESULTS
The results of measurement of IgE antibodies to partially purified ragweed AgE are shown in Figs. 2 Fig. 3 . Although the levels in the high dose group tended to be lower than those in the untreated group, this difference was not significant (Rank sum test; x-+ 1.52, P = 0.14).
In Fig. 4 the changes in IgE antibody from the initial value to the October value (A1-3) are shown. In all of the allergic groups the mean IgE antibody level increased during this period. In the untreated and low dose groups the change was significant (P < 0.01 by the sign test), and this was also the case with the high dose group (P < 0.01 by the signed rank test). These results indicate that immunotherapy did not completely suppress the rises in IgE antibody after the ragweed pollination season, even in the most intensively treated patients. Inspection of the individual rises in IgE antibody suggested that patients with high preseasonal levels had rises greater than patients with low preseasonal levels. Analysis of the relationship between the initial IgE antibody levels and the increases from July to October in the untreated group indicated that these were positively correlated, as shown in Fig. 5 . The relationship between the initial IgE antibody levels and the seasonal rises was even more striking when the high dose-treated group was analyzed (r, = + 0.65, P < 0.001).
Comparison of the maximal rises in IgE antibodies from the preseasonal to the October levels (A1l-3) indicated that the increase in IgE antibodies was less in the high dose-treated group than in the untreated group 20-(a) The levels of IgG antibody to ragweed AgE before and at the peak of the ragweed pollination season are shown in Fig. 6 . The nonallergic and allergic untreated groups had low levels of AgE binding, and neither group showed any rise in binding during the pollination season. The low dose group had binding levels comparable with both the nonallergic and untreated allergic groups before beginning hyposensitization in April. By August the IgG antibody level of the low dose group had risen significantly (P < 0.01). The high dose-treated group showed initial IgG antibody levels in July which were higher than those of the other three groups (P < 0.001), and even in August the IgG levels of the high dose group were greater (P < 0.01) than those of the low dose- Because IgG antibodies might influence the quantity of IgE antibody being produced, we compared the levels of IgG and IgE antibodies in the high dose group. As shown in Fig. 7 the antibody levels in these classes were positively related in serum obtained before the ragweed pollination season and also during the height of the pollination season. Furthermore, in the high dose group there was a tendency for the rises in IgE to parallel the level of IgG antibodies (r. = + 0.36; 0.05 <P < 0.1). In the low dose-treated group IgE and IgG antibody levels in August-September samples also tended to be related (r. = + 0.56; 0.05 < P < 0.1). IgE and IgG antibody levels were not related in the allergic untreated group at any time. 
DISCUSSION
In this study we have analyzed changes in IgE antibodies to ragweed antigens following the pollination season and the relationship of these changes to IgG antibodies. In normal subjects neither IgE antibody nor IgE protein changed appreciably during the study period (21) . IgE antibodies to AgE increased in the allergic subjects during the ragweed pollination season, a finding in keeping with prior measurements of IgE antibody to ragweed AgE by passive leukocyte sensitization (4, 6, 7) . Also, Berg and Johansson have found seasonal increases in IgE antibodies to timothy and birch pollen (22) . In the present study the maximal changes in IgE antibodies to AgE were usually found in October, and by January the levels had declined. The decrease in IgE antibody occurred in all of the allergic patients, even those receiving monthly injections of pollen extract. In a study of untreated patients in 1971 we found that no change in IgE antibody occurred from July 15 to August 20, but by early September 50% of the levels had increased significantly.' By mid-September the IgE antibody level had increased in almost all patients. In five of seven patients a further increase, usually slight, was seen between mid-September and mid-October. Thus, the level of IgE antibody likely reaches a maximum in October, although additional studies are needed to define this with precision.
Analysis of the changes in serum IgE antibodies after the ragweed pollination season revealed that the magnitudes of the rises were related to the preseasonal IgE antibody levels. This relationship was seen in the untreated patients with hay fever as shown in Fig. 5 (6, 7, 23) . The difference in our fesults and those in earlier studies may be due to differences in the methods used to measure IgE antibody activity, or possibly to differences in the study groups; most of the subjects studied earlier were children (6, 7) .
Because IgG antibody can reduce production of IgE antibody in experimental animals (24, 25) Changes in IgE Antibodies during Immunotherapti for Ragweed Hay Fever linearly proportional to the amount of serum added. When the RAST result in percent of total counts bound is plotted against the quantity of serum tested on log-log graph paper, the resultant curves approximate straight lines. Thus the response of a given patient could be expressed in terms of a reference serum, as is done by Johansson, Bennich, and Berg (11) . Because our results have been analyzed by nonparametric statistical methods, expression of the results in terms of percent of total counts bound should not influence the comparisons between the various groups. Measurement of IgE antibodies to partially purified ragweed AgE by RAST clearly distinguished the allergic serums from those of normal controls. Only once in 248 determinations was a serum misclassified, and after exposure to ragweed pollen this patient's IgE antibody level increased to a value greater than any of the normal subjects. Berg and Johansson have also noted that samples obtained long after exposure to antigen may not contain IgE antibody detectable by RAST (22) . Clearly, if RAST is used as a diagnostic test (5), serum samples should be otbained shortly after exposure to antigen, when leyels of IgE antibody should be high.
In addition to its relative technical simplicity, RAST would appear to be more sensitive than passive leukocyte sensitization for detection of IgE antibodies (6) , in that IgE antibody can be measured by the latter method in the serum of only half of adult patients with ragweed hay fever. Finally, the solid-phase ragweed antigen was remarkably stable, and even after storage for 1 yr at 4VC in the RAST buffer, its reactivity with a standard serum was essentially unchanged.
